Symbol
LRMR on Nasdaq
Investment type
Equity / Common Stock, par value $0.01 per share
Latest Disclosed Shares Owned
2,600,211 shares
Security Ownership %
4.1%
Shares, Excluding Options vs Price
Value, Excluding Options

THE GOLDMAN SACHS GROUP, INC. ownership in Larimar Therapeutics, Inc. Common Stock, par value $0.01 per share (LRMR)

13 May 2025 - THE GOLDMAN SACHS GROUP, INC. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,600,211 shares of Larimar Therapeutics, Inc. Common Stock, par value $0.01 per share (LRMR). This represents 4.1% ownership of the company. This is the first filing by GOLDMAN SACHS GROUP INC disclosing ownership of Larimar Therapeutics, Inc. Common Stock, par value $0.01 per share (LRMR).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.